Literature DB >> 16174668

Differential experiences of the psychobiological sequelae of ecstasy use: quantitative and qualitative data from an internet study.

Jacqui Rodgers1, Tom Buchanan, Carol Pearson, Andy C Parrott, J Ling, T M Hefferman, A B Scholey.   

Abstract

Previous work provided preliminary evidence that different patterns of use among ecstasy users may impact on perceived side-effects. Participants recruited via an ecstasy-related bulletin board differed in their responses compared to those recruited via other means. The present investigation compares self-reports of psychobiological difficulties among ecstasy users recruited either via a bulletin board or by alternative methods. Qualitative data included reports of any negative or positive changes attributable to ecstasy use and reasons for cessation of use. An Internet-based design was utilized and 209 volunteers completed the study, 117 of whom were recruited via a bulletin board devoted to discussion of ecstasy. Psychobiological difficulties attributable to ecstasy use varied, with mood fluctuation the most common. Differences between the two groups in the extent to which these problems were reported was found. Bulletin board recruits were less likely to report anxiety or poor concentration, but more likely to report tremors/twitches. For the whole sample, lifetime use was associated more with psychobiologial problems, although this pattern was stronger and more pervasive for the non-bulletin board participants. Bulletin board recruits were more aware of possible negative psychological effects and were more likely to report adopting harm reduction strategies. From the qualitative data three negative consequences of use were identified, the most common of which was "psychological problems". In support of the quantitative findings the likelihood of reporting psychological problems increased with lifetime exposure to ecstasy in both recruitment conditions but interestingly this did not appear to impact on reasons for cessation of use. Participants also reported a number of effects that they regarded as beneficial. Future research should also take these aspects of use into account.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16174668     DOI: 10.1177/0269881105058777

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


  26 in total

1.  Emotional traits predict individual differences in amphetamine-induced positive mood in healthy volunteers.

Authors:  Matthew G Kirkpatrick; Nicholas I Goldenson; Nahel Kapadia; Christopher W Kahler; Harriet de Wit; Robert M Swift; John E McGeary; Steve Sussman; Adam M Leventhal
Journal:  Psychopharmacology (Berl)       Date:  2015-10-02       Impact factor: 4.530

2.  Basal functioning of the hypothalamic-pituitary-adrenal (HPA) axis and psychological distress in recreational ecstasy polydrug users.

Authors:  Mark A Wetherell; Catharine Montgomery
Journal:  Psychopharmacology (Berl)       Date:  2013-11-05       Impact factor: 4.530

3.  Social facilitation of alcohol subjective effects in adolescents: Associations with subsequent alcohol use.

Authors:  Matthew G Kirkpatrick; Junhan Cho; Matthew D Stone; Dayoung Bae; Jessica L Barrington-Trimis; Raina D Pang; Adam M Leventhal
Journal:  Psychopharmacology (Berl)       Date:  2021-01-06       Impact factor: 4.530

4.  Effects of MDMA and Intranasal oxytocin on social and emotional processing.

Authors:  Matthew G Kirkpatrick; Royce Lee; Margaret C Wardle; Suma Jacob; Harriet de Wit
Journal:  Neuropsychopharmacology       Date:  2014-01-22       Impact factor: 7.853

5.  Executive function profile in the offspring of women that smoked during pregnancy.

Authors:  Brian J Piper; Selena M Corbett
Journal:  Nicotine Tob Res       Date:  2011-10-29       Impact factor: 4.244

6.  Intimate insight: MDMA changes how people talk about significant others.

Authors:  Matthew J Baggott; Matthew G Kirkpatrick; Gillinder Bedi; Harriet de Wit
Journal:  J Psychopharmacol       Date:  2015-04-28       Impact factor: 4.153

7.  MDMA does not alter responses to the Trier Social Stress Test in humans.

Authors:  Anya K Bershad; Melissa A Miller; Harriet de Wit
Journal:  Psychopharmacology (Berl)       Date:  2017-04-21       Impact factor: 4.530

Review 8.  A structured review of reasons for ecstasy use and related behaviours: pointers for future research.

Authors:  Gjalt-Jorn Ygram Peters; Gerjo Kok
Journal:  BMC Public Health       Date:  2009-07-13       Impact factor: 3.295

9.  In the company of others: social factors alter acute alcohol effects.

Authors:  Matthew G Kirkpatrick; Harriet de Wit
Journal:  Psychopharmacology (Berl)       Date:  2013-05-28       Impact factor: 4.530

Review 10.  Drug effects on responses to emotional facial expressions: recent findings.

Authors:  Melissa A Miller; Anya K Bershad; Harriet de Wit
Journal:  Behav Pharmacol       Date:  2015-09       Impact factor: 2.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.